293 related articles for article (PubMed ID: 33080989)
1. The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats.
Siracusa R; Fusco R; Cordaro M; Peritore AF; D'Amico R; Gugliandolo E; Crupi R; Genovese T; Evangelista M; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080989
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
Ardizzone A; Fusco R; Casili G; Lanza M; Impellizzeri D; Esposito E; Cuzzocrea S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671213
[TBL] [Abstract][Full Text] [Related]
3. A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Esposito E; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Gugliandolo E; Crupi R; Cuzzocrea S
Eur J Pharmacol; 2016 Jul; 782():107-18. PubMed ID: 27095683
[TBL] [Abstract][Full Text] [Related]
4. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.
Impellizzeri D; Bruschetta G; Cordaro M; Crupi R; Siracusa R; Esposito E; Cuzzocrea S
J Neuroinflammation; 2014 Aug; 11():136. PubMed ID: 25164769
[TBL] [Abstract][Full Text] [Related]
5. Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach.
Peritore AF; D'Amico R; Siracusa R; Cordaro M; Fusco R; Gugliandolo E; Genovese T; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073872
[TBL] [Abstract][Full Text] [Related]
6. Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat.
Peritore AF; Siracusa R; Fusco R; Gugliandolo E; D'Amico R; Cordaro M; Crupi R; Genovese T; Impellizzeri D; Cuzzocrea S; Di Paola R
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429243
[TBL] [Abstract][Full Text] [Related]
7. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
[TBL] [Abstract][Full Text] [Related]
8. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
[TBL] [Abstract][Full Text] [Related]
9. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
Impellizzeri D; Cordaro M; Bruschetta G; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
J Neurotrauma; 2017 Sep; 34(18):2609-2623. PubMed ID: 28095731
[TBL] [Abstract][Full Text] [Related]
10. Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells.
Iuvone T; Affaitati G; De Filippis D; Lopopolo M; Grassia G; Lapenna D; Negro L; Costantini R; Vaia M; Cipollone F; Ialenti A; Giamberardino MA
Pain; 2016 Jan; 157(1):80-91. PubMed ID: 25974242
[TBL] [Abstract][Full Text] [Related]
11. Micronized palmitoylethanolamide reduces joint pain and glial cell activation.
Bartolucci ML; Marini I; Bortolotti F; Impellizzeri D; Di Paola R; Bruschetta G; Crupi R; Portelli M; Militi A; Oteri G; Esposito E; Cuzzocrea S
Inflamm Res; 2018 Oct; 67(10):891-901. PubMed ID: 30121836
[TBL] [Abstract][Full Text] [Related]
12. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-Gallate Modulates Postoperative Pain by Regulating Biochemical and Molecular Pathways.
Siracusa R; Monaco F; D'Amico R; Genovese T; Cordaro M; Interdonato L; Gugliandolo E; Peritore AF; Crupi R; Cuzzocrea S; Impellizzeri D; Fusco R; Di Paola R
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206850
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
[TBL] [Abstract][Full Text] [Related]
16. Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylation.
Horvath RJ; Landry RP; Romero-Sandoval EA; DeLeo JA
Neuroscience; 2010 Aug; 169(2):843-54. PubMed ID: 20493931
[TBL] [Abstract][Full Text] [Related]
17. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
[TBL] [Abstract][Full Text] [Related]
18. Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease.
Cordaro M; Scuto M; Siracusa R; D'amico R; Filippo Peritore A; Gugliandolo E; Fusco R; Crupi R; Impellizzeri D; Pozzebon M; Alfonsi D; Mattei N; Marcolongo G; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2020 Mar; 34(3):4085-4106. PubMed ID: 31950563
[TBL] [Abstract][Full Text] [Related]
19. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
[TBL] [Abstract][Full Text] [Related]
20. Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats.
Ahmad A; Genovese T; Impellizzeri D; Crupi R; Velardi E; Marino A; Esposito E; Cuzzocrea S
Brain Res; 2012 Oct; 1477():45-58. PubMed ID: 23046519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
